At Infinity Med Spa, the most consequential enrollment question is not simply what the monthly price is. It is which published version of the program becomes your agreement. Its general weight-loss page, medication pages and membership page describe different starting prices—and, for Ozempic, different numbers of monthly appointments. Those differences affect both what a patient might pay and what the practice promises to provide. A free initial consultation is a useful opportunity to reconcile them, not evidence that starting treatment carries no additional charges.
Infinity advertises medically supervised weight management and GLP-1 injections for Valencia and Santa Clarita, California. Its public documentation describes clinical evaluation, possible prescribing, body-composition assessments and nutrition support. This review examines those offerings through the enrollment contract: the first payment, continuing responsibilities, medication arrangements and exit terms. The pages were consulted October 19, 2026; that is a research date, not confirmation of when each page was updated. The record supports a local GLP-1 offering, but not a single, consistently documented membership package.
At a glance
- Local practice
- Infinity lists 25425 Orchard Village Rd., Suite 180, Valencia, CA 91355, and advertises weight-management services for Valencia and Santa Clarita.
- Conflicting monthly prices
- Semaglutide appears from $195 monthly on the general page and from $395 on its medication page; tirzepatide appears from $295 and from $595, respectively.
- Additional entry charges
- The semaglutide and tirzepatide medication pages each list $200 laboratory testing and a $400 NP/PA consultation despite advertising a complimentary initial consultation.
- Ozempic medication is separate
- The practice lists an Ozempic pen at $1,300 and estimates approximately 12 weeks of use, separately from a monthly program charge.
Start with the agreement, not the headline price
Infinity presents itself as a Valencia med spa offering noninvasive cosmetic treatments alongside medical weight management. Its weight-loss page says clinicians may prescribe semaglutide, Ozempic or tirzepatide based on medical history and goals. That establishes an advertised service, not a guaranteed prescription or a standardized package available to every visitor. Before authorizing payment, the useful document is an individualized agreement identifying the program, medication, included appointments and charges that apply to that patient.
The public terminology does not settle the commitment. Infinity uses “membership,” “program” and monthly pricing, but the consulted material does not specify a minimum enrollment period, automatic-renewal mechanism or required prepayment. None should be inferred from the monthly amount. A price expressed per month also does not establish when payment is collected. Our guide to monthly billing and commitments explains why the billing interval and the length of an obligation need separate answers.
The discrepancy is not merely that a broad advertisement lacks detail. Different Infinity pages supply different numbers for similarly named offerings. A prospective member should ask the practice to identify the controlling offer and put its effective price, inclusions and renewal terms in writing. That would distinguish a genuine package difference from an outdated page without assuming either explanation. The public record alone does not establish which explanation is correct.
Reconcile the published packages line by line
The general weight-loss page advertises semaglutide from $195 per month and tirzepatide from $295. Their dedicated medication pages instead advertise semaglutide starting at $395 monthly and tirzepatide as low as $595 monthly. These are starting figures, not universal quotes. The dedicated pages describe monthly follow-up and treatment management, but do not uniformly establish whether the entire medication expense is included. It would be misleading either to call them all-inclusive or to dismiss the published amounts as unusable.
Ozempic has a similar split: the general page says as low as $195 monthly, while the membership page says as low as $395. Both separately list the $1,300 pen. The appointment benefit also changes from one monthly check-in on the general page to two on the membership page. That difference could materially affect the service purchased. Ask for the exact appointment count and whether the quoted monthly fee replaces, or is separate from, any medication charge.
Microdose memberships require their own reconciliation. The general page advertises semaglutide microdosing starting at $195 monthly and tirzepatide microdosing starting at $395; the tirzepatide medication page advertises its microdose membership starting at $295 and presents it as maintenance for patients who have already achieved initial weight loss, not as an alternative entry-level weight-loss program. The $395-versus-$295 price discrepancy remains unresolved. These labels do not establish formulation, quantity or individual clinical suitability. The following comparison preserves the published conditions rather than selecting the lowest price as the operative offer.
| Offering | General weight-loss page | Medication or membership page |
|---|---|---|
| Semaglutide program | As low as $195/month; free initial consultation | Starting at $395/month; $200 labs and $400 NP/PA consultation listed |
| Tirzepatide program | As low as $295/month; free initial consultation | As low as $595/month; $200 bloodwork and $400 NP/PA consultation listed |
| Ozempic program | As low as $195/month; one monthly check-in; $1,300 pen separate | As low as $395/month; two monthly check-ins; $200 bloodwork, $400 consultation and $1,300 pen listed |
| Semaglutide microdose membership | Starting at $195/month | Confirm applicable package and inclusions directly |
| Tirzepatide microdose membership | Starting at $395/month | Starting at $295/month on the tirzepatide page; presented as maintenance for patients who have already achieved initial weight loss |
Separate the free introduction from paid clinical intake
A complimentary initial consultation is consistently prominent, but it is not the only consultation described. The semaglutide page lists $200 for laboratory testing and $400 for a consultation with a nurse practitioner or physician assistant to review results and the treatment plan. The tirzepatide page likewise lists $200 bloodwork and a $400 NP/PA consultation to review results and medical history. The Ozempic membership page publishes the same two charges. These are material entry costs, even though the timing of collection is not established.
Infinity says its initial evaluation considers medical history, lifestyle habits and nutritional status. It may perform testing to investigate hormonal imbalances, nutrient deficiencies or food sensitivities. The general page’s Ozempic information also asks patients to supply bloodwork from the previous 12 months. That raises a practical contract question: will existing results satisfy the requirement, or is a new paid test still required? The documentation does not answer that consistently enough to assume a waiver.
Ask what the free consultation actually accomplishes, when the paid evaluation occurs and what happens financially if medication is not prescribed. The pages do not establish whether those clinical charges are refundable, credited toward membership or payable regardless of prescribing. A written GLP-1 quote should separate the introduction, laboratory work, clinical review, medication and recurring services rather than combining them under an unexplained first payment.
Define what continuing membership buys
The dedicated semaglutide page says its $395 monthly program includes one follow-up visit, weight and body-composition analysis, ongoing dosage management as needed, and complimentary nutrition guidance with a diet plan. The tirzepatide page assigns similar benefits to its $595 monthly program: one follow-up, body-composition analysis, personalized treatment adjustments and a diet plan. These are concrete advertised services. The agreement should clarify how visits are scheduled and whether unused appointments expire or carry forward.
The broader program describes possible dietary modifications, exercise recommendations, behavioral therapy and procedures. It also says body-composition analysis and metabolic testing help track progress and adjust treatment. “May include” is not a promise that every component is included in every monthly fee. In particular, the consulted documentation does not establish whether additional procedures, repeat laboratory work or extra clinical appointments are covered. Patients should distinguish the practice’s available capabilities from the benefits purchased under their specific membership.
There are also nonclinical membership benefits. Infinity advertises Ozempic and semaglutide members 20% off spa and laser services, 10% off injectables, 10% off skin-care products and 20% off weight-loss or health supplements. These are discounts on additional purchases, not included treatment or evidence of better outcomes. They should remain separate from the decision about whether the recurring clinical services justify the applicable fee.
Identify the product and the pharmacy before purchase
The semaglutide and tirzepatide pages describe instruction for once-weekly self-injection at home after prescribing. That establishes the advertised route and training process, but not the precise presentation supplied. The consulted material does not identify a dispensing pharmacy or establish whether unbranded semaglutide and tirzepatide refer to commercial products or compounded preparations. Nor does it document shipping, pickup, delivery timing or cold-chain arrangements. Those omissions should become questions before medication payment, not assumptions about how the practice operates.
Ozempic is more specifically described as a pen costing $1,300, which Infinity estimates lasts approximately 12 weeks. That is the provider’s estimate, not a guaranteed supply duration, individualized instruction or minimum enrollment term. The medication expense is separate from the advertised monthly program fee. Ask which pen presentation is being quoted, who dispenses it and what happens if the prescribed product or actual medication expense differs from the initial discussion.
FDA approval attaches to a specific product, not to a clinic or pharmacy. FDA says compounded preparations are not approved and recommends them when an individual’s medical needs cannot be met by an approved drug, with a prescription and state-licensed pharmacy; nonapproval alone does not establish clinical inequivalence. Our guide to product descriptions and formulations provides useful terminology. If an injectable delivery arrives warm or inadequately refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy.
Match care responsibilities to named people and contact paths
Infinity identifies Dr. Van J. Veloso as medical director and practice owner. Its team biographies present Nicole Phillips as an FNP-BC with a focus including weight management, and Kelly McCurdy as a PA-C with experience including medical weight loss. These are provider-published credentials and descriptions, not independently verified licensing findings. They also do not establish who will evaluate a particular patient, prescribe medication or handle an unexpected treatment concern.
The practice states that medical treatments are performed by a licensed physician, nurse practitioner, physician assistant or registered nurse. Those are different professional roles; the statement should not be read as a promise that every appointment is with a physician. An enrollment discussion should identify the treating clinician, the person responsible for prescription decisions and the route for reaching clinical staff between scheduled visits. The consulted material does not establish response-time guarantees or urgent-care availability.
The listed location is 25425 Orchard Village Rd., Suite 180, Valencia, CA 91355. Patients can call 661-220-5102, text 661-259-8100 or request a consultation through the website. Weight-loss consultations are advertised Monday through Saturday. General business hours are Monday through Friday, 9 a.m.–6 p.m., and weekends, 10 a.m.–5 p.m.; Sunday business hours do not establish Sunday weight-management appointments. Telemedicine and care outside California are not documented in the consulted material.
Get cancellation and refund rules beyond the website terms
The consulted pages do not establish how to cancel a weight-management membership, whether renewals are automatic, how much notice is required or whether there is a minimum commitment. They also do not specify missed-appointment charges or refund boundaries. That is an information gap, not proof that cancellation is prohibited or unrestricted. Request the actual treatment and payment agreement before authorizing recurring charges, including the effective cancellation date and the method the practice accepts for notice.
The website terms allow users to stop transactional SMS messages by replying STOP and seek assistance through HELP or contactus@infinitymedspa.com. Stopping those messages is not documented as cancellation of membership, treatment or payment authorization. Our guide to cancellation notice and renewal dates explains the distinction. Likewise, ending future services does not itself establish a refund for a completed visit, paid laboratory work or medication already ordered; Infinity’s specific boundaries need written confirmation.
The website is offered to users age 18 and older, but that is a website-access rule rather than a complete clinical eligibility policy. Its terms also select New York law and courts for website-related matters despite the practice’s California address. That mismatch deserves clarification if those terms are presented during enrollment, but the public text does not establish how a separate treatment agreement handles disputes. No conclusion about enforceability follows from this documentary review.
Keep financing, insurance and treatment decisions separate
Infinity advertises “0% Financing Options Available,” but the consulted text does not disclose the lender, eligibility requirements, repayment schedule or other financial conditions. That advertisement is not enough to establish the terms available to a particular patient. If financing is offered, ask for its separate agreement and how a treatment cancellation affects any remaining balance. The public documentation does not establish an optional payment plan’s details or that financing is required to enroll.
The reviewed material also does not explain health-insurance acceptance, submission of claims or insurer reimbursement. Do not interpret a published cash amount as proof either that insurance is excluded or that it will contribute. NIDDK notes that some plans cover weight-management medicines and others do not; medication coverage must be confirmed separately from coverage for a consultation. The practical question is which party, if any, will submit each charge and what the patient remains responsible for.
Finally, financial clarity cannot establish clinical benefit. Infinity’s consultation is supposed to determine candidacy, not automatically produce a prescription. NIDDK describes medication selection as a discussion of health conditions, other medicines, benefits, side effects and costs, with follow-up addressing tolerance and response. Those responsibilities matter when defining continuing services. The practice’s general marketing about weight management or microdosing should not be treated as independently measured outcomes for its patients or as a promise of maintained results after treatment stops.
Questions & answers
Does Infinity’s $195 Ozempic offer include the medication?
No. The general page separately lists a $1,300 Ozempic pen and describes the $195 monthly charge as covering a check-in, weight and body-mass assessment, and diet plan. The membership page instead advertises a starting monthly fee of $395 and two check-ins. Confirm which package applies; neither monthly headline should be treated as the total medication-inclusive price.
What might be charged after the free consultation?
The dedicated semaglutide and tirzepatide pages each list $200 laboratory testing and a $400 NP/PA consultation, alongside their respective starting monthly prices of $395 and $595. The Ozempic membership page also lists those clinical charges. The documentation does not establish a uniform first-payment amount or collection schedule, so request an itemized quote before proceeding.
Can I bring recent bloodwork instead of buying new tests?
The general page’s Ozempic information asks for bloodwork from the past 12 months, while other program descriptions publish a $200 testing charge. That does not establish that outside results automatically replace paid testing. Ask which results the clinician needs, whether your existing records are acceptable and whether any testing charge remains before scheduling the paid review.
Does replying STOP cancel my weight-loss membership?
The documented STOP instruction cancels SMS service only. It does not establish cancellation of treatment, membership or recurring payments. Ask Infinity for its membership cancellation method, notice deadline, effective date and confirmation process. Refund eligibility is a separate question, and the consulted public material does not define it.
Does Infinity identify the pharmacy or confirm compounded medication?
Not in the consulted material. The practice names semaglutide and tirzepatide and describes at-home injections, but does not establish the dispensing pharmacy or whether those unbranded offerings are commercial products or compounded preparations. Ask for the exact product, presentation, dispensing pharmacy and acquisition arrangements before purchase. Missing documentation does not prove that either formulation is used.
How do I arrange a weight-management consultation?
Infinity advertises free weight-loss consultations Monday through Saturday at its Valencia practice. It lists telephone contact at 661-220-5102, texting at 661-259-8100 and a website consultation request. Confirm appointment availability and whether the first visit is the complimentary introduction or a paid clinical review. The public material does not establish telemedicine access or service outside California.
Our assessment
Infinity Med Spa documents more than a medication advertisement: it describes clinical evaluation, monthly appointments, body-composition monitoring, nutrition support and named clinical staff. Those are useful foundations for a local weight-management service. The enrollment weakness is that its public pages do not converge on one price-and-service agreement, and they leave important renewal, cancellation, refund and pharmacy responsibilities unresolved. A reasonable next step for someone considering the practice is to request a dated, itemized agreement that reconciles the competing offers and identifies the exact medication and responsible clinician. The documentary record supports taking the service seriously as an advertised offering, but not treating the lowest headline price or a free consultation as a complete account of the financial commitment.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Infinity Med Spa / Infinity MedSpa — services/body/medical weight loss ↗
- Infinity Med Spa / Infinity MedSpa — about/financing ↗
- Infinity Med Spa / Infinity MedSpa — about ↗
- Infinity Med Spa / Infinity MedSpa — services/body/medical weight loss/semaglutide ↗
- Infinity Med Spa / Infinity MedSpa — about/memberships ↗
- Infinity Med Spa / Infinity MedSpa — about/meet our team ↗
- Infinity Med Spa / Infinity MedSpa — official website ↗
- Infinity Med Spa / Infinity MedSpa — services/body/medical weight loss/tirzepatide ↗
- Infinity Med Spa / Infinity MedSpa — terms of service ↗